Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF)

BIOLOGICAL2 trials

Sponsors

Sidney Kimmel Cancer Center at Thomas Jefferson University, BioVex Limited

Conditions

Hematologic MalignanciesMelanoma

Phase 1

Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation

CompletedNCT00429416

Sidney Kimmel Cancer Center at Thomas Jefferson UniversityHematologic Malignancies

Start: 2004-03-31End: 2009-05-31Updated: 2016-11-29

Phase 3

An Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in Melanoma

CompletedNCT01368276

BioVex LimitedMelanoma

Start: 2010-10-31End: 2014-09-30Updated: 2015-12-18